GRI Bio Inc (GRI) Stock Price, Quote, News & History

GRINASDAQ
$2.41
-0.20-7.66%
At close: Apr 22, 5:00 PM EST
$2.34
-0.27-10.34%
Pre-Market: 7:49 AM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-10.19M
Investing Cash Flow (TTM)
-3.00K
Financing Cash Flow (TTM)
13.39M
Free Cash Flow (TTM)
-10.19M
Capital Expenditure (TTM)
-3.00K
Net Change in Cash (TTM)
3.20M

Analyst Trends and Forecast

1
Dec 25
1
Mar
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
-$4.70M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
0.57
Earnings Yield % (TTM)
-5096.23%
Earnings Yield % (FWD)
-146.03%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$4.16

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$8.23M
Debt to Equity
0.01
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
$2.41
Volume / Avg.
411.00 / 376.58K
Day Range
- - -
52 Wk Range
2.10 - 80.36
Market Cap
$3.38M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
41
Short Interest
7.78%
Days to Cover
3.47

About

Sector
Health Care
Industry
Biotechnology
GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI B...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy GRI Bio (GRI) stock?

A

You can purchase shares of GRI Bio (NASDAQ:GRI) through any online brokerage.

View our list of the best stock brokerages

Q

What is the forecast, or price target, for GRI Bio (GRI) stock?

A

GRI Bio has a consensus price target of $25.00.

Q

What is the current price for GRI Bio (GRI)?

A

The stock price for GRI Bio (NASDAQ: GRI) is $2.34 last updated April 24, 2026 at 7:04 AM EDT.

Q

Does GRI Bio (GRI) pay a dividend?

A

There are no upcoming dividends for GRI Bio.

Q

When is GRI Bio (NASDAQ:GRI) reporting earnings?

A

GRI Bio does not have any upcoming earnings scheduled.

Q

Is GRI Bio (GRI) going to split?

A

There is no upcoming split for GRI Bio.

Q

What sector and industry does GRI Bio (GRI) operate in?

A

GRI Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.